Vitamins for Eyesight: Which Ones Actually Help?

Only a handful of vitamins and nutrients have strong clinical evidence behind them for specific eye conditions, and which ones matter depends entirely on what part of the eye you are worried about. Vitamin A remains foundational for basic visual function. Lutein and zeaxanthin protect the macula from light damage. A specific combination formula slows age-related macular degeneration in people already at risk. Beyond those, the picture gets murkier fast, with several popular supplements failing to deliver in rigorous trials despite decades of enthusiasm.

Vitamin A and the Basics of Seeing in the Dark

Vitamin A is the one nutrient whose connection to eyesight is genuinely ancient and well-proven. During World War I, a controlled clinical trial among malnourished Danish children with night blindness found that whole milk, butter, and cod-liver oil contained a fat-soluble substance that reversed the condition.¹ That substance turned out to be vitamin A, and the finding holds up more than a century later. Your retina uses vitamin A to manufacture rhodopsin, the light-sensitive pigment in rod cells that lets you see in dim conditions. Without enough of it, your ability to adapt from bright to dark environments deteriorates.

Modern research has gone further, showing that byproducts created during the vitamin A cycle in the eye actually slow down dark adaptation on their own. In mouse studies, selectively blocking these byproducts sped up recovery to dark-adapted vision, while deliberately increasing them slowed it down without otherwise damaging the retina.² This suggests that as you age and these byproducts accumulate, the decline in night vision many people experience is partly a vitamin A metabolism issue.

The practical reality is that outright vitamin A deficiency is rare in developed countries, so supplementing more will not sharpen your nighttime vision if your levels are already normal. But in populations with limited access to animal products and colorful vegetables, vitamin A deficiency remains a leading preventable cause of blindness worldwide.

Lutein, Zeaxanthin, and the Macular Filter

The macula, the small central zone of your retina responsible for sharp, detailed vision, concentrates two carotenoid pigments at remarkably high levels: lutein and zeaxanthin. A third related pigment, meso-zeaxanthin, is produced directly in the retina from lutein.³ The enzyme responsible for that conversion, RPE65, is the same one involved in the visual cycle that processes vitamin A.⁴

These pigments serve two protective roles. First, they physically filter blue light before it hits the photoreceptors underneath. In lab studies using liposomes, lutein and zeaxanthin reduced blue light transmission more effectively than beta-carotene or lycopene.⁵ Second, they neutralize reactive oxygen species generated when light energy hits retinal tissue, limiting the kind of cumulative oxidative damage that drives age-related macular degeneration.⁶

Your body cannot make lutein or zeaxanthin from scratch. They come from food: green leafy vegetables, orange and yellow fruits and vegetables, and egg yolks.⁷ Whether you get enough through diet or need a supplement depends on how much of these foods you regularly eat, a question that comes up again when we look at absorption from food versus pills.

The AREDS Formula and Macular Degeneration

The most rigorously tested eye supplement in existence is the AREDS formula, developed through two large government-funded trials. The original AREDS study showed that a combination of vitamin C, vitamin E, beta-carotene, zinc, and copper slowed progression to advanced age-related macular degeneration in people who already had intermediate disease. The follow-up trial, AREDS2, tested whether swapping out beta-carotene for lutein and zeaxanthin, and adding omega-3 fatty acids, would improve results.

The initial AREDS2 results were somewhat ambiguous. In the primary analysis, adding lutein and zeaxanthin to the base formula did not produce a statistically significant reduction in progression to advanced disease.⁸ But the long-term follow-up, tracked out to ten years, told a clearer story. Participants assigned to lutein and zeaxanthin had about a 9% lower risk of progression to late macular degeneration compared to those not assigned to it. Among people who had been taking beta-carotene specifically, switching to lutein and zeaxanthin cut progression risk by roughly 20%.⁹

Zinc plays a distinct role in this formula. The retinal pigment epithelium, the tissue layer just behind the retina, contains the highest zinc concentration of any tissue complex in the eye. Both deficiency and excess zinc can lead to cellular dysfunction there, and zinc supplementation has become a core part of the standard preventive approach for macular degeneration.¹⁰

A critical point: the AREDS formula is designed for people with intermediate or advanced macular degeneration in one eye. If your eyes are healthy, there is no evidence that taking this combination prevents the disease from starting in the first place.

Omega-3 Fatty Acids Disappoint for Dry Eye

Fish oil supplements are one of the most commonly recommended remedies for dry eye disease, and many eye doctors still suggest them. The evidence, however, has not been kind. The largest trial on this question, called DREAM, enrolled over 500 people with moderate-to-severe dry eye and gave half of them high-dose omega-3 supplements. After a year, there was no meaningful difference between the supplement group and placebo in symptom scores, corneal staining, tear breakup time, or tear production.¹¹

A separate prevention-focused trial followed more than 23,000 healthy adults for over five years and found that omega-3 supplementation did not reduce the incidence of new dry eye disease. The rate was 2% in both the treatment and placebo groups.¹² Smaller, older studies had suggested benefit, which is likely why the recommendation persists, but the large rigorous trials have not supported it for either treatment or prevention.

Vitamin C, Vitamin E, and Cataracts

The lens of your eye is particularly vulnerable to oxidative damage over a lifetime, which is why cataracts are so common in older adults. Vitamins C and E, both potent antioxidants, have long been studied for a possible protective role. An early case-control study comparing cataract patients with matched cataract-free subjects found that the cataract-free group used significantly more supplementary vitamins C and E, suggesting a possible risk reduction of at least half.¹³

Subsequent, larger prospective work tempered those findings. A study tracking women over time found that vitamin C showed only a weak, non-significant inverse association with cataract risk, and three randomized trials of combined antioxidant treatment found no major benefit for up to six and a half years. Vitamin E fared slightly better: higher total intake from food and supplements was linked to about a 14% reduced risk of cataract, driven mainly by women in the highest intake group.¹⁴

Where vitamin C shows clearer promise is in corneal healing after injury. It speeds up corneal epithelial cell growth and plays a role in collagen production in the cornea.¹⁵ In animal studies of alkali burns, topical vitamin C applied in the first several days reduced inflammation, activated corneal stem cells, and cut down on scarring and abnormal blood vessel growth.¹⁶ This is a clinical application, not a daily supplement story, but it illustrates that vitamin C’s role in the eye extends beyond the lens.

Vitamin B3 and Glaucoma

Glaucoma damages the retinal ganglion cells, the neurons that carry visual information from your eye to your brain. The research on nicotinamide, a form of vitamin B3, is one of the more exciting developments in recent eye nutrition science, though it is still early. In aged mice engineered to develop glaucoma, oral nicotinamide prevented the disease in 93% of eyes at the highest dose tested.¹⁷

The mechanism appears to involve restoring levels of NAD+, an energy-related molecule that declines with age and is found at low levels in the blood of glaucoma patients.¹⁸ In rat models, a nicotinamide-enriched diet provided dose-dependent protection of the retinal ganglion cell dendrites, the branching structures through which these neurons communicate, and preserved healthy metabolic activity in the optic nerve.¹⁹

A small crossover clinical trial in human glaucoma patients showed improved inner retinal function with supplementation. These results are genuinely promising, but the human evidence remains thin. Nobody should replace their glaucoma medication with vitamin B3 based on what exists so far. Larger, longer human trials are needed before this becomes a standard recommendation.

Benfotiamine and Diabetic Eye Disease

High blood sugar damages the tiny blood vessels in the retina through several biochemical pathways simultaneously. Benfotiamine, a fat-soluble derivative of thiamine (vitamin B1), was shown in animal studies to block three of these major damage pathways at once by boosting the activity of a specific enzyme that diverts harmful sugar metabolites into safer routes. In the retinas of diabetic animals, this treatment prevented experimental diabetic retinopathy.²⁰

At a cellular level, both thiamine and benfotiamine completely prevented the death of retinal pericytes, the cells that wrap around and support capillaries in the retina, when those cells were exposed to the kind of damage caused by high glucose.²¹ Loss of pericytes is one of the earliest visible signs of diabetic retinopathy, so protecting them is a meaningful target. As with vitamin B3 and glaucoma, though, the human clinical trial evidence is not yet robust enough to make definitive recommendations.

Vitamin D and Myopia

Because spending more time outdoors as a child appears to reduce the risk of developing nearsightedness, researchers wondered whether vitamin D, which your skin makes from sunlight, might be the protective factor. The answer seems to be no. A prospective birth cohort study found that when both outdoor time and vitamin D levels were included in the same analysis, vitamin D had no independent association with incident myopia, while time outdoors retained a strong protective link.²²

A more recent prospective cohort studying children’s serum vitamin D over time came to a similar conclusion, suggesting that factors like ethnicity, near-work habits, and lighting conditions play more significant roles in myopia development than vitamin D status.²³ Vitamin A showed no association with myopia either.²⁴ The protective ingredient in outdoor time is probably the bright ambient light itself, which appears to influence how the eye grows during development, not any vitamin produced along the way.

Astaxanthin and Digital Eye Strain

If you spend hours at a screen and notice your eyes feeling fatigued, you may have come across astaxanthin, a red-orange carotenoid found in algae and salmon. A few small trials have explored it for screen-related eye fatigue. In one study of healthy adults with eye strain from display terminal work, six weeks of consuming a combination of anthocyanin, astaxanthin, and lutein prevented some of the decline in focusing ability that long screen sessions normally produce.²⁵

A separate trial of an astaxanthin-containing diet in healthy individuals similarly suggested effects on ciliary muscle tension, which controls the eye’s ability to shift focus between near and far distances.²⁶ However, a trial in children found no significant differences between astaxanthin and placebo on measures like visual acuity, tear production, or focusing distance.²⁷ The results are mixed, the studies are small, and most use combination products rather than isolated astaxanthin, making it hard to know which ingredient is doing what.

Your Genetics May Change Which Supplements Work

One of the more surprising findings in eye supplement research is that the same formula can help some people and potentially harm others, depending on their genetic makeup. A study of participants in the original AREDS trial found that people carrying risk variants in a gene called CFH benefited most from antioxidants alone, and adding zinc actually negated those benefits. Meanwhile, people carrying risk variants in a different gene, ARMS2, benefited most from zinc-containing regimens, and antioxidants alone appeared to increase their risk. People homozygous for risk variants in both genes got no benefit from any AREDS treatment category.²⁸

A validation analysis reinforced this, showing that the AREDS formula modified the risk of progression to the wet form of macular degeneration based on individual genetics. Individuals with high CFH risk and no ARMS2 risk who took the AREDS formula actually had increased progression compared to placebo.²⁹ This is a genuinely unsettling result because most doctors prescribe the standard AREDS2 formula without genetic testing. It raises the possibility that a one-size-fits-all approach to macular degeneration supplements is wrong for a meaningful fraction of patients. Genetic testing for these variants is commercially available, but incorporating it into routine clinical practice has been slow.

Food Versus Pills for Eye Nutrients

For lutein and zeaxanthin specifically, how you get them matters. Egg yolks turn out to be a surprisingly efficient delivery vehicle. The lutein in egg yolk sits inside a digestible lipid matrix of cholesterol, triglycerides, and phospholipids, and the cholesterol content appears to enhance absorption. In a controlled study, lutein from eggs was more bioavailable than the same amount from either supplements or spinach.³⁰

Another study measured the effect of egg yolks on plasma carotenoid levels directly. Adding egg yolks to a diet increased plasma lutein by 28 to 50% and plasma zeaxanthin by 114 to 142%, depending on the background fat in the diet.³¹ That said, eggs are not a high-dose source. If you have intermediate macular degeneration and your doctor recommends AREDS2-level doses of lutein and zeaxanthin (10 mg and 2 mg daily), you would need to eat an unreasonable number of eggs to get there. For general maintenance, though, regularly eating eggs and dark leafy greens goes a long way toward keeping your macular pigment density up without any supplement at all.

Supplement Safety and What the Label Actually Contains

High-dose eye supplements are not without risks. Vitamin A should be avoided by women who may become pregnant, people with liver disease, and heavy drinkers. Beta-carotene, which was in the original AREDS formula, was linked to increased lung cancer risk in men who smoke, which is why AREDS2 replaced it with lutein and zeaxanthin. Vitamin E and ginkgo biloba have blood-thinning effects that can be dangerous for people on anticoagulant therapy.³²

There is also a quality problem. An analysis of commercially available AREDS2-style supplements found that most deviated substantially from the actual AREDS2 formula. On average, vitamin C levels were about 52% lower than recommended, vitamin E about 61% lower, and zinc about 40% lower.³² A separate review of available products found that while some matched the recommended formulation, many contained one or more ingredients at lower-than-specified doses.³³ If you are taking an eye supplement because your doctor recommended it for macular degeneration, it is worth comparing the label to the actual AREDS2 formulation rather than assuming that any product marketed for “eye health” contains the right ingredients at the right doses.

What the Evidence Does Not Support

The gap between marketing and evidence is wide in the eye supplement world. There is no credible evidence that any vitamin or supplement will improve normal, healthy vision. No pill will make you see more sharply, eliminate the need for reading glasses, or reverse established refractive errors like nearsightedness or farsightedness. Vitamin D does not prevent myopia in children. Omega-3 supplements do not treat or prevent dry eye disease at a population level. Mega-doses of individual antioxidants have not been shown to prevent cataracts in randomized trials, even though observational data hinted they might.

Where vitamins and minerals genuinely help is in specific clinical scenarios: slowing progression of intermediate macular degeneration, treating deficiency-related night blindness, potentially supporting retinal ganglion cells in glaucoma (pending more human data), and protecting against hyperglycemic damage in diabetic retinopathy. These are targeted applications for specific conditions, not broad insurance policies for general eye health. The most eye-protective behavior for the average person remains eating a varied diet rich in colorful vegetables, leafy greens, and fish, spending time outdoors, managing blood sugar and blood pressure, not smoking, and getting regular eye exams.